Wang Carolyn, Ramsey Allison, Lang David, Maria Copaescu Ana, Krishnan Pranay, Kuruvilla Merin, Mervak Benjamin, Newhouse Jeffrey, Sumkin Alisa, Saff Rebecca
Department of Radiology, University of Washington, 1959 NE Pacific St, Seattle, WA 98195.
Division of Allergy/Immunology and Rheumatology, Rochester Regional Health, Division of Allergy/Immunology, University of Rochester, Rochester, NY.
Radiology. 2025 May;315(2):e240100. doi: 10.1148/radiol.240100.
Intravenous iodinated contrast media (ICM) is widely used in the United States, and it is imperative to provide guidance on the management of adverse reactions to ICM as well as the preparation, planning, and potential premedication for patients with previous reactions. Currently there is a discordance between the American College of Radiology Contrast Manual, which recommends premedication to prevent repeat hypersensitivity reactions to ICM, and the Anaphylaxis 2020 Practice Parameters Update, which recommends against routine administration of glucocorticoids and/or antihistamines to prevent anaphylaxis with prior ICM hypersensitivity reactions. A task force of experts from radiology who are also members of the American College of Radiology Committee on Drugs and Contrast Media and expert allergists/immunologists including members of the Adverse Reactions to Drugs, Biologics and Latex Committee of American Academy of Allergy, Asthma & Immunology evaluated the scientific evidence to develop consensus recommendations that are endorsed by both organizations. The task force took into account the strength of evidence and balanced the potential risks of recurrent reactions with those of premedication and product avoidance when making these recommendations to improve and standardize the care of patients who experience or have a history of reaction to ICM. © Radiological Society of North America and American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc on behalf of American Academy of Allergy, Asthma & Immunology and by Radiological Society of North America. All rights are reserved, including those for text and data mining, AI training, and similar technologies. This paper was jointly developed by and jointly published by Elsevier Inc and Radiological Society of North America. The articles are identical except for minor stylistic and spelling differences in keeping with each journal's style. Either citation can be used when citing this article. Contrast allergy, Contrast hypersensitivity, Iodinated contrast allergy, Iodinated contrast hypersensitivity, Anaphylaxis, Contrast skin testing, Contrast switching, Contrast reaction, Delayed contrast reaction, Immediate contrast reaction.
静脉注射碘化造影剂(ICM)在美国被广泛使用,因此有必要就ICM不良反应的管理以及既往有反应患者的准备、规划和潜在的预处理提供指导。目前,美国放射学会造影剂手册建议进行预处理以预防对ICM的重复过敏反应,而《2020年过敏反应实践参数更新》则建议不要常规使用糖皮质激素和/或抗组胺药来预防既往ICM过敏反应引发的过敏反应,两者之间存在不一致。一个由放射学专家组成的特别工作组,他们也是美国放射学会药物与造影剂委员会的成员,以及包括美国过敏、哮喘与免疫学会药物、生物制剂和乳胶不良反应委员会成员在内的过敏症专家/免疫学家,对科学证据进行了评估,以制定得到两个组织认可的共识性建议。特别工作组在提出这些建议时考虑了证据的强度,并权衡了复发反应的潜在风险与预处理和避免使用产品的风险,以改善和规范对经历过或有ICM反应病史患者的护理。©北美放射学会和美国过敏、哮喘与免疫学会。由爱思唯尔公司代表美国过敏、哮喘与免疫学会以及北美放射学会出版。保留所有权利,包括文本和数据挖掘、人工智能训练及类似技术的权利。本文由……联合开发,并由爱思唯尔公司和北美放射学会联合发表。除了为符合各期刊风格而存在的细微文体和拼写差异外,文章内容完全相同。引用本文时可使用任一参考文献。造影剂过敏、造影剂超敏反应、碘化造影剂过敏、碘化造影剂超敏反应、过敏反应、造影剂皮肤试验、造影剂转换、造影剂反应、延迟造影剂反应、即刻造影剂反应。